ArticleMolecular cancer therapeutics2015

Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors.

Ronit Mazor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.